Pituitary and growth

Growth hormone neurosecretory dysfunction as part of the spectrum of growth hormone deficiency disorders which benefit from growth hormone treatment

ea0051p039 | Pituitary and growth

Can the TSH index be used as a predictor of central hypothyroidism in children?

ea0051p040 | Pituitary and growth

UK Consensus Statements for the diagnosis of growth hormone deficiency (GHD)

ea0051p041 | Pituitary and growth

ACTH deficiency and potential for reversibility in children and young people (CYP) with craniopharyngioma

ea0051p042 | Pituitary and growth

Height as a clinical biomarker of disease burden in adult mitochondrial disease

ea0051p043 | Pituitary and growth

SOX3 gene duplication (OMIM 313430) associated with midline CNS malformations, hypopituitarism and neurodevelopmental abnormalities: 3 unrelated cases

ea0051p044 | Pituitary and growth

Changing patterns of growth in children with prader-willi syndrome

ea0051p045 | Pituitary and growth

Growth hormone secreting adenomas and the challenges of treatment in children

ea0051p046 | Pituitary and growth

Association between congenital hypopituitarism and agenesis of the internal carotid artery

ea0051p047 | Pituitary and growth

Frequency of cranial MRI abnormalities in isolated growth hormone deficiency over a 20-year period

ea0051p048 | Pituitary and growth

Growth hormone use in prader-willi syndrome – Experience of a dedicated paediatric clinic

ea0051p049 | Pituitary and growth

Comparison of insulin tolerance test to arginine test for the diagnosis of growth hormone deficiency in children

ea0051p050 | Pituitary and growth

Siblings with 3-M Syndrome show good response to Growth Hormone (GH) therapy over a 4 year follow-up growth data

ea0051p051 | Pituitary and growth

Nurses’ viewpoints on growth hormone delivery devices

ea0051p052 | Pituitary and growth

IGF-1 titration of GH in Turner syndrome

ea0051p053 | Pituitary and growth

Growth hormone treatment in a regional centre: licensed and unlicensed indications

ea0051p054 | Pituitary and growth

An audit assessing the monitoring of sleep disordered breathing in children on GH therapy with Prader Willi syndrome

ea0051p055 | Pituitary and growth

Long-term unidentified complication of IGF-I treatment: Pulmoner hypertension

ea0051p056 | Pituitary and growth

Embedding electronic growth charts into clinical practice at a children’s hospital

ea0051p057 | Pituitary and growth

Analysis of UK patients in PATRO children: a non-interventional study of the long-term safety and efficacy of Omnitrope in children

ea0051p058 | Pituitary and growth

Growth hormone treatment in children: an audit of compliance with NICE Guidance

ea0051p059 | Pituitary and growth

Improvement in motor function after growth hormone replacement in children with growth hormone deficiency and developmental delay

ea0051p060 | Pituitary and growth

Endocrine Abstracts

45th Meeting of the British Society for Paediatric Endocrinology and Diabetes

Poster Presentations

Congenital hypopituitarism and hyperinsulinaemic hypoglycaemia: a challenging association

Growth hormone neurosecretory dysfunction as part of the spectrum of growth hormone deficiency disorders which benefit from growth hormone treatment

Can the TSH index be used as a predictor of central hypothyroidism in children?

UK Consensus Statements for the diagnosis of growth hormone deficiency (GHD)

ACTH deficiency and potential for reversibility in children and young people (CYP) with craniopharyngioma

Height as a clinical biomarker of disease burden in adult mitochondrial disease

SOX3 gene duplication (OMIM 313430) associated with midline CNS malformations, hypopituitarism and neurodevelopmental abnormalities: 3 unrelated cases

Changing patterns of growth in children with prader-willi syndrome

Growth hormone secreting adenomas and the challenges of treatment in children

Association between congenital hypopituitarism and agenesis of the internal carotid artery

Frequency of cranial MRI abnormalities in isolated growth hormone deficiency over a 20-year period

Growth hormone use in prader-willi syndrome – Experience of a dedicated paediatric clinic

Comparison of insulin tolerance test to arginine test for the diagnosis of growth hormone deficiency in children

Siblings with 3-M Syndrome show good response to Growth Hormone (GH) therapy over a 4 year follow-up growth data

Nurses’ viewpoints on growth hormone delivery devices

IGF-1 titration of GH in Turner syndrome

Growth hormone treatment in a regional centre: licensed and unlicensed indications

An audit assessing the monitoring of sleep disordered breathing in children on GH therapy with Prader Willi syndrome

Long-term unidentified complication of IGF-I treatment: Pulmoner hypertension

Embedding electronic growth charts into clinical practice at a children’s hospital

Analysis of UK patients in PATRO children: a non-interventional study of the long-term safety and efficacy of Omnitrope in children

Growth hormone treatment in children: an audit of compliance with NICE Guidance

Improvement in motor function after growth hormone replacement in children with growth hormone deficiency and developmental delay

A novel IGSF1 mutation in a large Irish kindred highlights the need for family screening in the IGSF1 deficiency syndrome

BiosciAbstracts